Similarly, physiologically-based modeling has demonstrated that ERPs and ongoing EEG activity can be integrated within the same framework [49], [50].
Through competitions, privacy-preserving genomic data analysis models have demonstrated potential value with respect to the safeguarding of potentially sensitive information while supporting important studies.
Recent developments in nonlinear reduced-order models have demonstrated efficient computation of the dynamic response.
Numerous animal models have demonstrated that active immunotherapy can induce disease-modifying levels of auto-antibodies.
Experimental models have demonstrated that TKIs exhibit differential efficacy depending on which mutations are present.
Animal models have demonstrated great utility in developing an understanding of the etiology and mechanisms of many diseases.
Recent models have demonstrated how an attractive combination of stiffness, strength, and toughness can be achieved through the staggered structure.
The experimental results on many 3D models have demonstrated the effectiveness and robustness of the proposed segmentation method.
Studies using ALS mouse models have demonstrated that overexpression of human wild-type SOD1 (hSOD1) can co-aggregate and accelerate disease of the hSOD1-G85R expressing mouse, but not that of mice expressing murine SOD1-G86R17,18.
Preclinical models have demonstrated encouraging signs of anti-tumor activity through antibody-dependent cell-mediated cytotoxicity.
Some cancer models have demonstrated the anti-tumor activities of IL-12 (Colombo and Trinchieri, 2002).
